oa SA Pharmaceutical Journal - New drug focus
Antiretroviral update - Reyataz(R), Truvada(R) and Viread(R)
Several antiretrovirals for the management of HIV-1 infection have recently been registered in South Africa. Since antiretrovirals are not used as monotherapy and since several treatment guidelines are available on the appropriate use of antiretroviral medicines in South Africa, it was decided to discuss three of the recently registered antiretrovirals together and to highlight where they fit into HIV treatment regimens.
Article metrics loading...